Literature DB >> 23258458

Irukandji syndrome: a widely misunderstood and poorly researched tropical marine envenoming.

Teresa J Carrette1, Avril H Underwood, Jamie E Seymour.   

Abstract

Irukandji syndrome is a poorly defined set of symptoms that occur after envenoming by certain species of jellyfish, primarily cubozoans or 'box jellyfish'. Envenomed victims can show symptoms ranging from headaches, severe pain, nausea and vomiting to pulmonary oedema, cardiac failure and severe hypertension resulting in death. Historically, this syndrome appears to have been misdiagnosed and reported cases are undoubtedly a significant underestimation of the prevalence of this syndrome. The variation in symptoms has resulted in a myriad of treatments though none has been established as definitive. Effective pain relief with opioids is the most immediate priority. Although the annual numbers of envenomations are generally low, the associated financial costs of this envenomation may be comparatively high, with suggestions that it could run to millions of dollars per season in northern Australia alone. The syndrome has been well documented from many areas along the east coast of northern Australia, leading to the belief that it is an Australian oddity. However, with an increase in medical knowledge and improved diagnosis of the condition, it appears that envenomations causing Irukandji syndrome are an increasing marine problem worldwide.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258458

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  10 in total

1.  Prey Capture Ecology of the Cubozoan Carukia barnesi.

Authors:  Robert Courtney; Nik Sachlikidis; Rhondda Jones; Jamie Seymour
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

2.  Early life history of Alatina cf. moseri populations from Australia and Hawaii with implications for taxonomy (Cubozoa: Carybdeida, Alatinidae).

Authors:  Teresa Carrette; Ilka Straehler-Pohl; Jamie Seymour
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 3.  Impact of Scyphozoan Venoms on Human Health and Current First Aid Options for Stings.

Authors:  Alessia Remigante; Roberta Costa; Rossana Morabito; Giuseppa La Spada; Angela Marino; Silvia Dossena
Journal:  Toxins (Basel)       Date:  2018-03-23       Impact factor: 4.546

4.  Isolation, Structure Determination, and Synthesis of Cyclic Tetraglutamic Acids from Box Jellyfish Species Alatina alata and Chironex yamaguchii.

Authors:  Justin Reinicke; Ryuju Kitatani; Shadi Sedghi Masoud; Kelly Kawabata Galbraith; Wesley Yoshida; Ayako Igarashi; Kazuo Nagasawa; Gideon Berger; Angel Yanagihara; Hiroshi Nagai; F David Horgen
Journal:  Molecules       Date:  2020-02-17       Impact factor: 4.411

5.  Environmental drivers of the occurrence and abundance of the Irukandji jellyfish (Carukia barnesi).

Authors:  Olivia C Rowley; Robert Courtney; Tobin Northfield; Jamie Seymour
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

Review 6.  Raising Awareness on the Clinical and Forensic Aspects of Jellyfish Stings: A Worldwide Increasing Threat.

Authors:  Sara Almeida Cunha; Ricardo Jorge Dinis-Oliveira
Journal:  Int J Environ Res Public Health       Date:  2022-07-10       Impact factor: 4.614

7.  Statolith Morphometrics Can Discriminate among Taxa of Cubozoan Jellyfishes.

Authors:  Christopher J Mooney; Michael J Kingsford
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

8.  Thermal and Osmotic Tolerance of 'Irukandji' Polyps: Cubozoa; Carukia barnesi.

Authors:  Robert Courtney; Sally Browning; Tobin Northfield; Jamie Seymour
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

9.  Early Life History of the 'Irukandji' Jellyfish Carukia barnesi.

Authors:  Robert Courtney; Sally Browning; Jamie Seymour
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

10.  Bay watch: Using unmanned aerial vehicles (UAV's) to survey the box jellyfish Chironex fleckeri.

Authors:  Olivia C Rowley; Robert L Courtney; Sally A Browning; Jamie E Seymour
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.